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Helminth parasites are of considerable medical and economic importance. Studies of the immune response against helminths
are of great interest in understanding interactions between the host immune system and parasites. Eﬀector immune mechanisms
against tissue-dwelling helminths and helminths localized in the lumen of organs, and their regulation, are reviewed. Helminth
infections are characterized by an association of Th2-like and Treg responses. Worms are able to persist in the host and are
mainly responsible for chronic infection despite a strong immune response developed by the parasitized host. Two types of
protection against the parasite, namely, premune and partial immunities, have been described. Immune responses against
helminths can also participate in pathogenesis. Th2/Treg-like immunomodulation allows the survival of both host and parasite
by controlling immunopathologic disorders and parasite persistence. Consequences of the modiﬁed Th2-like responses on co-
infection, vaccination, and inﬂammatory diseases are discussed.
1.Introduction
Many species of helminths are parasitic multicellular organ-
isms of medical and economic importance as they infect
humans and animals and sometimes provoke fatal diseases
such as schistosomiasis. They can also be responsible for
economic losses due to decreased milk or meat production
and the cost of anthelminthic treatments of parasitized
individuals. Helminths are extremely diverse. They can be
classiﬁedinto3taxonomicgroups,thatis,nematodes,trema-
todes, and cestodes, often with very diﬀerent parasitic cycles.
For example, (i) they may be transmitted orally (Strongyles,
Fasciola sp., etc.) by transcutaneous route (Ankylostoma sp.,
Strongylo¨ ıdes sp., Schistosoma sp., etc.) by an arthropod
vector (Onchocerca volvulus, Diroﬁlaria immitis, etc.); (ii)
theirdeﬁnitive and intermediate hosts range frommammals,
birds, reptiles to ﬁsh, molluscs and arthropods, and so forth;
(iii) they may be localized in organ lumen or in tissues such
as gut, liver (parenchyma and bile ducts), lung, lymphatic
vessels, and so forth; (iv) the successive developmental stages
of parasitic species may infect diﬀerent tissues and cells of
diﬀerent organs.
Despite this great complexity, helminths usually cause
asymptomatic or subclinical chronic infection, although
some parasitized individuals can suﬀer from severe disease
which may be fatal. Indeed, worms tend to be aggregated in
their distribution, with a large number of hosts harboring
few parasites and few heavily infected hosts [1, 2]. This
remarkable equilibrium between most hosts and parasites is
the product of long-term coevolution of the two partners
and particularly of the immune defence of the host and the
immune evasion of the parasite. The immune responses of
the hosts to helminth infection are generally characterized
by a skewed Th2-like response. Helminths have developed
several means of escaping these immune responses. Recently,
Maizels et al. [3] called them “masters of immunomod-
ulation”. These immunomodulatory abilities enable the
worm to persist in the host and can lead to interactions
with inﬂammatory and immune mechanisms involved in
other infections or to vaccines or in allergic and autoim-
mune diseases. The focus in this review is on pathogenic
helminths of veterinary importance, especially in Ruminants
medicine, and includes Fasciola spp. and gastrointestinal
nematodes.2 Journal of Biomedicine and Biotechnology
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Figure 1: Immune mechanisms and regulation induced against Fasciola hepatica. Two main immune mechanisms are directed against F.
hepaticaintheliverparenchyma:(i)duringtheearlyphaseofinfection,classicallyactivatedmacrophagesmayinducenitricoxideproduction
which is toxic for the ﬂuke. This mechanism needs to be conﬁrmed and may be upregulated by Th1-type cytokines and downregulated by
IL-10 produced by T regulatory cells. (ii) During the chronic phase of infection, antibody-dependent cellular cytotoxicity (ADCC) allows
the release of toxic mediators such as major basic protein, eosinophil cationic protein, and reactive nitrogen intermediates. This mechanism
is upregulated by Th2-type cytokines. T regulatory cells (Treg cells) produce IL-10 TGFβ which inhibit the production and function of Th1
cytokines.TheydownregulateanyexcessiveTh2responseintheimmunopathogenesisoffasciolosis.Finally,alternativeactivatedmacrophage
(AAMφ) produces molecules that are toxic to the ﬂuke and participates in ﬁbrosis and tissue repair.
2. Effector ImmuneMechanisms against
Helminths andTheir Regulation
Helminth infections are typically associated with hypere-
osinophilia, considerable IgE production, mucous masto-
cytosis, and goblet cells hyperplasia [4]. These immune
parameters are involved in diﬀerent eﬀector mechanisms
highly depending on where the helminth is localized.
2.1.EﬀectorMechanismsagainstTissue-DwellingParasitesand
Escape Mechanisms Developed by the Parasite. Several mech-
anisms against tissue-dwelling parasites have been described.
These parasites are mainly larval stages, for example, of
trematodes (Schistosoma spp., Fasciola spp.)o rn e m a t o d e s ,
which migrate through tissue.
Antibody Dependent Cellular Cytotoxicity (ADCC) is
dependent on eosinophils, neutrophils, macrophages, or
p l a t e l e t sa se ﬀector cells and IgE, IgG, or IgA as anti-
bodies. The parasitic structures covered by antibodies are
destroyed by cells carrying receptors to the Fc fragment
(RFc) (Figure 1). When these cells are activated by ﬁxation
of the antibodies to the RFc, they release products that are
toxic to the worm (major basic protein, eosinophil cationic
protein, eosinophil-derived neurotoxin, reactive nitrogen
intermediates,...). ADCCs are alsoableto immobilize nema-
todelarvalstagesastheymigratethroughthegutmucosa[5–
8].
A granuloma can occur around the parasite in the
tissue which stops the worm migration and development.
This phenomenon has been well investigated for Schisto-
soma mansoni. The granuloma is composed of eosinophils,
macrophages, and lymphocytes with an increasingly ﬁbrotic
extracellular matrix [4], which surrounds and segregates the
eggs from the hepatic tissue [9]. In the long term, ﬁbrosis
may develop as the eggs die and the granuloma is resolved
[9].
Finally, nitric oxide (NO), toxic to the worm, is released
by the macrophages classically activated by IFNγ and TNFα
(Figure 1). This mechanism has been described mainly
against trematodes (S c h i s t o s o m as p . ,F a s c i o l as p . ) during
acute infection, before egg production in Schistosoma man-
soni [10–12].
Tissue-dwelling parasites have developed several mecha-
nismstoescapetotheeﬀectorresponseofthehost(Figure 2).
Forexample,Fasciola sp. escapesfromtheimmuneresponses
by diﬀerent means as follows:
(i) Fasciola gigantica produces superoxide dismutase
which neutralizes superoxide radicals toxic for juve-
niles [13, 14].
(ii) F. hepatica releases cathepsin L-protease which
cleaves IgE and IgG involved in the ADCC [15].
(iii) Juvenile ﬂukes were found to be covered by IgM
[16]. While eosinophils do not express Fcμ receptor,
IgM deposition on ﬂuke tegument could inhibit
eosinophil adhesion. IgG2 produced during fasciolo-
sis in susceptible sheep [17] has been also suspected
to be a blocking immunoglobulin of the ADCC.
Furthermore, F. hepatica secretes several molecules able
to modulate the immune response. Excretory-secretory
products of F. hepatica (ESPFh) can depress the sheep and
rat lymphocytes stimulation [18, 19] and induce eosinophilJournal of Biomedicine and Biotechnology 3
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Figure 2: Main evasion mechanisms developed by Fasciola spp. against ADCC. Three main evasion mechanisms have been described: (i)
productionofsuperoxidedismutaseandGlutathioneS-transferasewhichneutralizesuperoxideradicals,(ii)cleavageofIgEandIgGinvolved
in the ADCC, and (iii) production of blocking antibodies IgM and IgG2 which could inhibit eosinophil adhesion to ﬂukes.
apoptosis [20]. Milbourne and Howell (1990, 1993) [21, 22]
have shown that there is an “IL5-like” substance in the
excretory-secretory products (ESPs) probably responsible
in part of the local and systemic eosinophilia observed
during fasciolosis. Cathepsin L-proteases induce a decrease
of lymphoproliferation in sheep and of the CD4 expression
on human and ovine T cells [23]. GST from F. hepatica
induces a signiﬁcant inhibition of nitrite production by rat
peritoneal macrophages [18].
2.2. Eﬀector Mechanisms against Parasites Localized in the
Lumen of Ducts and Escape Mechanisms Developed by the
Parasite. Intestinal anaphylaxis, with IgE-induced mast cells
degranulation, is responsible for changes in the intestine
physiology as well as architecture and chemistry of the
gut epithelium, including stimulation of ﬂuid, electrolyte
and mucus secretion, smooth muscle contractility, increased
vascular and epithelial permeability, and recruitment of
immunecellssuchaseosinophilormastcells[24](Figure 3).
This can lead to rapid elimination of the gastrointestinal
larvae, before they reach their tissue niche, and to expulsion
of the adult [25]. Furthermore, IgA on the surface of the gut
mucosa helps to neutralize the metabolic enzymes released
by digestive strongyles and interfere with the worm’s ability
to feed [26, 27].
As for tissue-dwelling parasites, parasites localized in the
l u m e no fd u c t sa r ea b l et op r o d u c ei m m u n o m o d u l a t o r y
substances to escape to the host immune responses. For
example, Necator americanus secretes a metalloprotease
which cleaves eotaxin, a chemotactic factor for eosinophils
[28]. Gastrointestinal nematodes produce also superoxide
dismutase and glutathione S-transferase which neutralize
toxic oxide radicals [29]. A cystatin produced by H. contortus
and N. brasiliensis modulates the antigen presentation to T
cells by inhibiting cysteine proteases of antigen presenting
cells, involved in the processing of the antigen [30, 31].
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Figure 3: Immune response against gastrointestinal nematodes
(GNE: eosinophil granulocyte, HS1: type 1 hypersensitivity).
Against larva, ADCC and type 1 hypersensitivity are involved to
block their migration in gut mucosa and to eliminate the parasite.
Against adult in the lumen of gut, intestinal anaphylaxis responsible
for muscle contractility, mucus secretion, and so forth, leads to the
expulsion of the parasite. IgA neutralizes the metabolic enzymes
and interferes with the worm’s ability to feed.
2.3. Regulation of Immune Responses against Helminths. All
these mechanisms, except the classically activated macro-
phages, are regulated by Th2-like cytokines and immu-
nomodulatory cell types (Figure 1). Interleukin-4 is involved
in the IgE isotype-switched B-cell responses, IL-5 is involved
in the production of eosinophils, and IL-13 has similar
functions to IL-4 and is involved mainly in the eﬀector
phase of inﬂammation and the development of ﬁbrosis [9].
T regulatory cells produce the suppressive cytokines IL-
10 and TGF-β which have antiinﬂammatory eﬀects and4 Journal of Biomedicine and Biotechnology
could be involved in the skewed Th2-like responses. Immune
deviation may also be promoted by the development of a
Th2-driving dendritic cell population induced by excretory-
secretory antigens from N. brasiliensis [32] or soluble egg
antigen from schistosome [33]. Finally, IL-4 and IL-13 are
able to alternatively activate macrophages (AAMps) which
have strong antiinﬂammatory properties, enhance Th2 cell
diﬀerentiation, contribute to ﬁbrosis, and repair at the site
of injury [34]. Thus, an environment, with downregulated
proinﬂammatory responsiveness, activated damage repair
mechanisms, and a controlled development of Th2-like anti-
parasite eﬀector responses is created during infection with
helminths [35].
Several proteins produced by helminths were involved
in the regulation of cytokine production [36, 37]. Schis-
tosome soluble egg antigen contains molecules as alpha-1
or omega-1 that initiate a Th2-like response [38–40]. ES-
62, a leucine aminopeptidase secreted by Acanthocheilonema
vitae, reduces CD4+ cell IL-4 and IFNγ production but
promotes IL-10 production by peritoneal B1 cells [41, 42].
It also inhibits the antigen-presenting cells ability to produce
IL12p70 and drives Th2-like diﬀerentiation in vitro [43,
44]. Helminths could also secrete cytokine homologues
as macrophage migration inhibitory factor (MIF) which
induces,withIL-4,thedevelopmentofalternativelyactivated
macrophage [45].
3.Protective and Immunopathological Effects
of the ImmuneResponse againstHelminths
Despite the Th2-like response induced against helminths,
these parasites are often able to persist in the host for a
long time, resulting in chronic infection. However 2 types
of immunity evaluated from the partial elimination of
settled parasites and from host resistance to reinfection
have been described, namely, premune immunity and partial
immunity.
Premune immunity against helminths is very common
and particularly observed against gastrointestinal strongyles.
Premunition or concomitant immunity has been deﬁned
by MacDonald et al. [9] as a state wherein the host is
protected from further infection with a given species by
ongoing persistent infection with the same organism. Thus
immune mechanisms existing concomitantly with parasites
(adults and encysted larval stages) in animals infected by
gastrointestinal nematodes prevent the establishment of new
larvae. In contrast, the elimination of adult worms by the
phenomenonof“self-cure”(spontaneousexpulsionofadults
by massive larval invasion during a short period of exposure)
or by anthelminthic treatment results in the installation of
new larvae until an equilibrium state is obtained. Premune
immunitycanalsobeexpressedasareductioninadultworm
size and in female worm fertility. In contrast, the primary
immune response against Fasciola hepatica in bovine limits
the number of metacercariae which develops in adults and
reduces the fertility of the females [46]. However it is unable
topreventtheestablishmentofnewparasites,whichisagreat
diﬀerence with the premune immunity [46]. It also permits
partial expulsion of adults in the bile ducts of infected cattle.
So, immune responses against Fasciola hepatica partially
protect the host against the infection.
Eﬀector mechanisms regulated by Th2-like responses
play a major role in immune protection to strongyles.
Comparison of the immune responses of diﬀerent breeds of
sheeptoHaemonchuscontortusrevealed a greater production
of Th2-like cytokines (IL-4, IL-5, IL-13) in resistant breeds
[47]. Similarly, Balb/c mice, which develop a Th2-like
response against Trichuris muris, were soon able to eliminate
the parasite, in contrast to AKR mice which express Th1-like
responses and chronic infection with the same parasite [48].
The protective role of Th1- and Th2-like responses during
ﬂuke infection is less clear: Th1-like responses might act
on larvae migrating through the liver parenchyma whereas
the chronic phase with F. hepatica might be due to Th2-
like responses against which the ﬂuke has developed several
escape mechanisms [46]. As described during infection with
Schistosoma mansoni, Th2-like responses are predominant
during infection by F. hepatica but early Th1-like responses
seem to be involved in protection against this parasite.
Indeed, sheep susceptible to F. hepatica develop a mixed
Th1- and Th2-like response with IFNγ and IL-10 production
during the ﬁrst 6 weeks of infection, whereas the immune
response of sheep resistant to F. gigantica is Th1 like, with
production of IFNγ only. This suggests that protection
against Fasciola sp. is linked with Th1-cytokine production
[49].Similarly,vaccinaltrialswithcathepsinL-proteasefrom
F. hepatica proved that protection induced by this antigen is
mediated by a Th1-like response [50].
Although the host immune reaction against helminths
may control the infection, it can also be responsible for
tissue lesions and symptoms which are often the primary
cause of disease during worm infection. Immunopathologic
phenomena have been thoroughly investigated in infections
with Schistosoma spp.A sd e s c r i b e da b o v ef o rF. hepatica
infection, acute schistosomosis is associated with Th1-like
responses against adult parasites. The Th2-like responses,
induced as a result of egg antigens secretion, downregulate
the production and eﬀector functions of Th1-like mediators
[51, 52]. When Th2-like responses against the eggs were
blocked experimentally, an exacerbated granuloma driven
by Th1 and Th17 cells resulted in hepatic damage and
death [53]. Granulomatous responses evolve from an early
Th1- to a sustained and dominant Th2-like response [54].
Whereas tissue ﬁbrosis stimulated by Th2-like cytokine (IL-
13) promotes tissue healing, excessive ﬁbrosis may become
pathogenic with loss of hepatic functions and portal hyper-
tension [54, 55]. It seems that during trematode infec-
tions Th1-like responses are more protective than Th2-like
responses against which these parasites have developed many
escape mechanisms. Although Th1-like responses are closely
associated with immunopathogenesis, Th2-like responses
mayalsocontributetoinﬂammatorydamage.Tregcellsseem
to regulate this detrimental immune response by suppressing
the Th1-like response and by downregulating any excessive
Th2-like response during granuloma formation [56].
Granuloma formation dependent on the Th2-like
response is also observed during gastrointestinal nematode
infection. A recent study has shown that experimentalJournal of Biomedicine and Biotechnology 5
downregulation of the Th2-like response to Nippostrongylus
brasiliensissuppressesresistancetogastrointestinalnematode
infection, pulmonary granulomatous inﬂammation, and
ﬁbrosis [57]. Similarly bovine ostertagiosis is associated with
diarrhoea, inappetence, and weight loss. These clinical signs
could result from smooth muscle contractility, increased
mucus production, loss of specialized cells in the abomasal
epitheliums induced by IgE-mediated immediate hypersen-
sitivity reactions, and degranulation of mast and goblet cells
and of proinﬂammatory mediators [24, 58].
Hence, protection against gastrointestinal nematodes
and against tissue-dwelling trematodes is controlled by Th2-
andTh1-likeresponses,respectively[59].Themigrationstep
in tissue is considered an immunoevasive strategy due to the
predominant Th2-like response during helminth infection
whereas protection in tissue is mediated by the Th1-like
response [59]. However, the immune mechanisms, particu-
larly those regulated by Th1-like cytokines, are responsible
for considerable immunopathological damage and for the
clinical signs observed during a helminthic disease. Even
if the immune responses against most of helminths are
orchestrated by Th2-like cytokines, the worms are still
able to persist in the host for a long time. Indeed, the
immune response during the chronic phase of infection
was recently reported to be a modiﬁed Th2-like response,
that is, a Th2-like response associated with Treg activity
and the production of antiinﬂammatory cytokines such
as IL-10 and TGFβ [60]. The induction of immunomod-
ulatory Th2/Treg responses would allow the survival of
both partners, by downregulating the host’s inﬂammatory
response and the immunopathological lesions observed
during helminth infection, and also the protective immune
mechanisms directed against the parasite [61, 62].
4. Helminths andCoinfection
Some helminths are able to downregulate the Th1-like res-
ponse because their high immunomodulator activity allows
the induction of Th2/Treg-type responses. Indeed F. hepatica
inhibits the Th1-like response induced by Bordetella pertussis
in mice [63]. Similarly F. hepatica is also able to change
the predictive value of the tuberculosis diagnosis test by
modifying the immune response against Mycobacterium
bovis [64]. Helminths can aﬀect the evolution of coinfection
by making animals more resistant to pathogens in which
protection is mediated by the Th2-like response and more
susceptible to pathogens in which protection is mediated
by the Th1-like response [9]. For example, the expulsion
of T. muris by mice is dependent on the Th2-like response.
Curry et al. [65] demonstrated that mice susceptible to
T. muris and coinfected with S. mansoni which induced
the Th2-like response were able to eliminate T. muris by
producing Th2-like cytokines. In contrast, mice infected
with S. mansoni were more susceptible to Toxoplama gondii
(protected by the Th1-like response) by inducing high
mortality and weak production of IFNγ and NO, compared
to mice solely infected with T. gondii [66]. Helminths were
also able to inhibit the development of protective immunity
regulated by Th1-like cytokines against Plasmodium sp.[ 62].
Many analyses of helminth - Plasmodium coinfections have
provided controversial results as the parasite burden of
Plasmodium sp. is dependent on the helminth species used,
the intensity and duration of worm infection, and the age of
the individual under study [67].
Helminths inﬂuence not only host resistance to another
pathogen but also the gravity of the resulting disease.
Cerebral malaria is associated with an overproduction of
proinﬂammatory cytokines. Helminth infections are able to
decrease the production of these cytokines by secreting IL-
10 and TGFβ and thereby diminish the risk of severe disease
[62]. The nematode Heligmosomoides polygyrus promotes
an immune response regulated by Th2-like cytokines, alter-
native activated macrophages, and regulatory T cells, and
hence, prevents the inﬂammatory reaction controlled by Th1
cytokines and severe immunopathological lesions observed
during schistosomosis [68]. Trichinella spiralis infection
limits pulmonary damage induced by inﬂuenza virus in mice
[69]. In contrast, H. polygyrus promotes intestinal lesions
due to bacteria such as Citrobacter rodentium by alternative
activation of macrophages [70].
However,otherpathogenscanalsoinﬂuencetheimmune
response against helminths. For example, Miller et al. [71]
recently showed that the production of Th1-like cytokines
andclassicactivationofmacrophageswerelittlealteredwhen
F. hepatica infection preceded or succeeded T. gondii infec-
tions, whereas the production of F. hepatica-speciﬁc Th2-
like cytokines and recruitment of AAMp were suppressed
by T. gondii infection. Similarly, neutrophil-activating pro-
tein from Helicobacter pylori downmodulated the Th2-like
response to Trichinella spiralis infection [72].
The eﬀects of helminths on infections with other path-
ogens are complex and dependent on many factors such as
the helminth species, coinfecting pathogen, protective and
pathological immune mechanisms, and also the host and the
individual.
5. Helminths andVaccination
Several studies have shown that helminths can inﬂuence
vaccine eﬃcacy by modulating host immune response, in
particular when Th1-like and cellular-dependent responses
are required. Schistosoma sp.a n dOnchocerca volvulus infec-
tions decrease the eﬃcacy of vaccine against tuberculosis
or tetanus [62], and Ascaris suum alters the eﬃcacy of
vaccine against Mycoplasma hyopneumoniae [73]. In mice,
H. polygyrus was able to downregulate the strong immunity
against Plasmodium chabaudi induced by blood stage anti-
gens [74]. Eﬀects of helminth infections on vaccine eﬃcacy
must be taken into account when using vaccines and also
when developing new vaccines, in particular by choosing
adapted adjuvants which are able to counterbalance the
immunomodulatory activities of the helminth.
6.HelminthsandAllergicand
Autoimmune Diseases
For several years, epidemiologic observations have shown
that the prevalence of helminth infection is decreasing in6 Journal of Biomedicine and Biotechnology
westernized countries whereas the prevalence of diseases
due to immune or inﬂammatory disorders such as aller-
gic or autoimmune diseases is increasing. Epidemiologic
and experimental data prove that chronic infection with
helminths is protective against allergy. Humans infected with
worms rarely develop allergic reactions [9] and an allergic
reaction against ovalbumin was inhibited in mice infected
with H. polygyrus or Schistosoma sp.[ 62, 75]. Similarly,
immunization with Toxascaris leonina-derived proteins was
able to inhibit allergy-speciﬁc Th2-like responses to oval-
bumin [76]. Treatment against gastrointestinal nematodes
increases cutaneous reactivity against house-dust mites [77].
These results are paradoxical because allergy is linked to
mastocyte degranulation by IgE; the production of which
is stimulated by helminths. In fact, worms induce the
production of large quantities of antiinﬂammatory cytokines
(IL-10, TGFβ) by the regulatory T cells which then inhibit
allergic inﬂammation.
In the same way, helminths can protect the host against
autoimmune disease or at least decrease the gravity of symp-
toms induced by autoimmune inﬂammation. For example,
S. mansoni infection inhibits the development of type 1
diabetes in NOD mice [78]o ro fe x p e r i m e n t a la u t o i m m u n e
encephalomyelitis in mice [79]. Helminth-speciﬁc Treg cells
and their antiinﬂammatory cytokines (IL-10, TGFβ)s e e m
to be largely implicated in the inﬂammatory disorders
associated with allergic diseases. Several studies are currently
underway to investigate the possibility of treating allergic
inﬂammatory diseases with immunomodulatory molecules
fromhelminths,withspecialfocusonthemoleculesinvolved
and the ways in which helminths manipulate the host
response, particularly how they activate and induce the
expansion of Treg cells.
7. Immunomodulatory Molecules of Helminths
As New Antiinﬂammatory Drugs
Immunomodulatory function of helminths and their prod-
ucts could be used as antiinﬂammatory drugs. Trichuris suis
has been tested recently to treat patients with inﬂammatory
bowel disease and Crohn’s disease with success [80, 81].
An excretory-secretory protein of Acanthocheilonema vitae,
ES62, has been well studied for its antiinﬂammatory prop-
erty. ES62 signiﬁcantly decreases the severity of collagen-
induced arthritis in mice [80] and of cutaneous hyper-
sensitivity dependant on mast cells [81]. However, these
immunomodulatory molecules could have side eﬀects by
increasing the risk of infections. Furthermore, they could
be responsible for allergic reactions because they could be
allergens or they could cross-react with allergens derived
from pollen or another source [82].
Inconclusion,helminthspecieshavecoevolvedwiththeir
host for a long time. This has led to a strict adaptation
which enables them to settle and persist in the host.
Helminths are strong immunomodulators able to interfere
with immune and inﬂammatory mechanisms induced by
themselves and by coinfecting pathogens, inﬂammatory
disorders, or vaccine. Immunomodulatory products from
helminths are probably the antiinﬂammatory molecules of
the future. Eﬀects of helminths on the host immune system
arenotproperlyknownbecausedataarepartialorcannotbe
generalized between species. Nevertheless these eﬀects need
to be taken in account when controlling helminths and the
diseases induced by worms. However, an individual could
be infected by several pathogens and it will be necessary to
evaluate the overall immune equilibrium resulting from the
immune interaction between host and pathogens in diﬀerent
tissues and organs, which is still diﬃcult, for instance.
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